Literature DB >> 11038236

Inhibition by curcumin of diethylnitrosamine-induced hepatic hyperplasia, inflammation, cellular gene products and cell-cycle-related proteins in rats.

S E Chuang1, A L Cheng, J K Lin, M L Kuo.   

Abstract

Curcumin (CCM), a major yellow pigment of turmeric obtained from powdered rhizomes of the plant Curcuma longa Linn, is commonly used as coloring agent in foods, drugs and cosmetics. In this study we report that gavage administration of 200 mg/kg or 600 mg/kg CCM effectively suppressed diethylnitrosamine (DEN)-induced liver inflammation and hyperplasia in rats, as evidenced by histopathological examination. Immunoblotting analysis showed that CCM strongly inhibited DEN-mediated the increased expression of oncogenic p21(ras) and p53 proteins in liver tissues of rats. In cell-cycle-related proteins, CCM selectively reduced the expression of proliferating cell nuclear antigen (PCNA), cyclin E and p34(cdc2), but not Cdk2 or cyclin D1. Moreover, CCM also inhibited the DEN-induced increase of transcriptional factor NF-kappa B. However, CCM failed to affect DEN-induced c-Jun and c-Fos expression. It has become widely recognized that the development of human hepatocellular carcinoma (HCC) is predominantly due to the chronic inflammation by virus, bacteria or chemical. Our results suggest a potential role for CCM in the prevention of HCC.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11038236     DOI: 10.1016/s0278-6915(00)00101-0

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  29 in total

1.  The combined effect of encapsulating curcumin and C6 ceramide in liposomal nanoparticles against osteosarcoma.

Authors:  Santosh S Dhule; Patrice Penfornis; Jibao He; Michael R Harris; Treniece Terry; Vijay John; Radhika Pochampally
Journal:  Mol Pharm       Date:  2014-01-24       Impact factor: 4.939

2.  The antibacterial activity of traditionally used Salvadora persica L. (miswak) and Commiphora gileadensis (palsam) in Saudi Arabia.

Authors:  Abdulbasit I I Al-sieni
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-11-02

Review 3.  Discovery of curcumin, a component of golden spice, and its miraculous biological activities.

Authors:  Subash C Gupta; Sridevi Patchva; Wonil Koh; Bharat B Aggarwal
Journal:  Clin Exp Pharmacol Physiol       Date:  2012-03       Impact factor: 2.557

Review 4.  Potential effects of curcumin on peroxisome proliferator-activated receptor-γ in vitro and in vivo.

Authors:  Mohsen Mazidi; Ehsan Karimi; Mohsen Meydani; Majid Ghayour-Mobarhan; Gordon A Ferns
Journal:  World J Methodol       Date:  2016-03-26

5.  Curcumin suppresses gastric NF-kappaB activation and macromolecular leakage in Helicobacter pylori-infected rats.

Authors:  Kawiya Sintara; Duangporn Thong-Ngam; Suthiluk Patumraj; Naruemon Klaikeaw; Tanittha Chatsuwan
Journal:  World J Gastroenterol       Date:  2010-08-28       Impact factor: 5.742

6.  Curcumin: a unique antioxidant offers a multimechanistic approach for management of hepatocellular carcinoma in rat model.

Authors:  Hanaa H Ahmed; Wafaa Gh Shousha; Aziza B Shalby; Hatem A El-Mezayen; Nora N Ismaiel; Nadia S Mahmoud
Journal:  Tumour Biol       Date:  2014-11-05

7.  Activation of PPARgamma is required for curcumin to induce apoptosis and to inhibit the expression of extracellular matrix genes in hepatic stellate cells in vitro.

Authors:  Shizhong Zheng; Anping Chen
Journal:  Biochem J       Date:  2004-11-15       Impact factor: 3.857

Review 8.  Pathogenesis of liver cirrhosis.

Authors:  Wen-Ce Zhou; Quan-Bao Zhang; Liang Qiao
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

9.  Sequential analysis of diethylnitrosamine-induced hepatocarcinogenesis in rats.

Authors:  Ryo Abe; Jun-Ichi Okano; Ryu Imamoto; Yuki Fujise; Yoshikazu Murawaki
Journal:  Exp Ther Med       Date:  2011-12-15       Impact factor: 2.447

10.  Mechanisms for the activity of heterocyclic cyclohexanone curcumin derivatives in estrogen receptor negative human breast cancer cell lines.

Authors:  Tiffany J Somers-Edgar; Sebastien Taurin; Lesley Larsen; Anupama Chandramouli; Mark A Nelson; Rhonda J Rosengren
Journal:  Invest New Drugs       Date:  2009-10-09       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.